ctrl K

Price Alert

Assembly Biosciences Inc. (ASMB)

NASDAQ: ASMB · Real-Time Price · USD

25.13

0.17 (0.68%)

At close: Aug 15, 2025, 3:07 PM

Assembly Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	38.34M	19.84M	52.42M	45.63M
Short-Term Investments	73.73M	110.41M	39.19M	101M
Long-Term Investments	n/a	n/a	n/a	27.97M
Other Long-Term Assets	312K	312K	78K	1.7M
Receivables	400K	43K	944K	336K
Inventory	n/a	-3.2M	n/a	n/a
Other Current Assets	3.02M	3.5M	4.41M	7.24M
Total Current Assets	115.5M	133.79M	96.97M	154.2M
Property-Plant & Equipment	3.35M	2.72M	3.94M	7.18M
Goodwill & Intangibles	n/a	n/a	n/a	-1.54M
Total Long-Term Assets	3.67M	3.04M	4.83M	36.86M
Total Assets	119.17M	136.82M	101.79M	191.06M
Account Payables	585K	461K	2.49M	2.66M
Deferred Revenue	37.62M	30.91M	2.73M	2.73M
Short-Term Debt	n/a	n/a	3.36M	3.15M
Other Current Liabilities	9.13M	1.15M	2.86M	3.27M
Total Current Liabilities	47.8M	39.23M	16.3M	16.07M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	35.38M	n/a	n/a	n/a
Total Long-Term Liabilities	38.01M	56.5M	2.83M	6.06M
Total Liabilities	85.81M	95.73M	19.13M	22.13M
Total Debt	3.09M	2.34M	3.46M	6.48M
Common Stock	7K	5K	49K	48K
Retained Earnings	-825.92M	-785.75M	-724.52M	-631.43M
Comprehensive Income	-211K	-81K	-803K	-419K
Shareholders Equity	33.36M	41.1M	82.66M	168.93M
Total Investments	73.73M	110.41M	39.19M	128.97M